PTC Therapeutics, Inc. (PTCT)
66.71
+2.22
(+3.44%)
USD |
NASDAQ |
Mar 16, 16:00
66.71
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics Profit Margin (Quarterly) : -81.96% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.91% |
| Insmed, Inc. | -124.5% |
| Sarepta Therapeutics, Inc. | -93.07% |
| Keros Therapeutics, Inc. | -6.09K% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 27.17% |
| Return on Invested Capital | 2.74K% |
| Gross Profit Margin (Quarterly) | 90.10% |
| Operating Margin (Quarterly) | -49.57% |
| Return on Net Operating Assets | 100.3% |